Planmeca Emerald® intraoral scanner data can now be used for producing SomnoDent® sleep apnea devices

SomnoMed manufactures the world’s leading OAT (Open Airway Therapy) oral appliances for sleep apnea treatment under the SomnoDent® brand. By establishing a seamlessly integrated workflow for ordering SomnoDent oral appliances directly from the Planmeca Romexis® software, Planmeca extends the range of solutions available for Planmeca Emerald® users for sleep apnea treatments.

The Planmeca Emerald intraoral scanners and the Romexis software are now smoothly integrated into SomnoMed’s sleep apnea device manufacturing workflow. The workflow only includes three easy steps:

1. Scan a patient’s upper and lower teeth. Place the SomGauge instrument, which is used to construct accurate and reliable bite records, in the patient's mouth when scanning the bite.
2. Fill-in the digital SomnoMed Order Sheet and import it into the Romexis software.
3. Send the filled-in order sheet and the patient's intraoral scans scanned in the SomGauge bite position to your local SomnoMed laboratory via the Planmeca Romexis Cloud service.

“Working with SomnoMed has been very smooth as we have together strived to find the best possible workflow for our shared customers. Through this global collaboration, we are looking forward to expanding the range of oral appliances that are manufactured based on the Planmeca Emerald intraoral scanner data even further,” says Ville Salonen, Planmeca’s Product Line and Business Development Manager for Orthodontics and CMF Surgery.

“SomnoMed is dedicated to a treatment-focused and technology-driven service offering. The SomnoDent and Planmeca Emerald integration offers dental professionals a high-quality and seamless digital workflow process to decrease costs and increase value, making it easy to expand their dental sleep treatment offering. This workflow automates the back-office operations, minimises potential errors and ensures the delivery of the mandibular advancement devices (MAD) in the fastest and most accurate way possible,” explains Frantz Jaeger, SomnoMed’s Director for Operations and Financial Control.

About SomnoMed

Founded in 2004, SomnoMed is an Australian medical device company operating in 28 countries. With headquarters in Sydney, Australia and offices in Europe and the United States, SomnoMed focuses on developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). More than 625,000 patients around the world with mild and moderate OSA have been successfully treated with SomnoMed’s custom-made oral appliances.
https://somnomed.com

Planmeca Oy and Planmeca Group

Planmeca Oy is one of the world's leading dental equipment manufacturers, with a product range covering digital dental units, CAD/CAM solutions, world-class 2D and 3D imaging devices and comprehensive software solutions. Privately owned and headquartered in Helsinki, Finland, the company offers a portfolio of products distributed in over 120 countries worldwide. Planmeca Oy is part of the Finnish Planmeca Group, which consists of several healthcare technology brands, each committed to innovation and design. With 4,500 employees worldwide, Planmeca Group companies achieved a combined turnover of EUR 1.1 billion in 2020.
www.planmeca.com